FDA Approves RHA Filler for Midface Contour Deficiencies
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
Researchers evaluated a proprietary dual hyaluronic acid complex designed to promote tissue remodeling through biomaterial-based regenerative biostimulation rather than localized inflammation.